DANIELLE SKARDA: Open Payments
NPI 1083151583 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,077 in 49 payments from 17 companies in 2025. Trend: 2023 $2,522 · 2024 $3,281 · 2025 $3,077
Food & beverage: $2,477Consulting: $600
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 1 | $600 |
| ABBVIE INC. | 6 | $410 |
| Arcutis Biotherapeutics, Inc. | 9 | $393 |
| Incyte Corporation | 5 | $334 |
| Galderma Laboratories, L.P. | 6 | $254 |
| Journey Medical Corporation | 2 | $235 |
| PFIZER INC. | 5 | $215 |
| Novartis Pharmaceuticals Corporation | 4 | $182 |
| Janssen Biotech, Inc. | 1 | $116 |
| UCB, Inc. | 1 | $104 |
Products named: SOFDRA, Zoryve, Opzelura, NEMLUVIO, Rhapsido, SKYRIZI, BOTOX, LITFULO.
Industry payments across FL — which companies pay providers there.
